These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10543754

  • 1. Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.
    Goldstein EJ, Citron DM, Vreni Merriam C, Tyrrell K, Warren Y.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2726-30. PubMed ID: 10543754
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
    Goldstein EJ, Citron DM, Warren Y, Tyrrell K, Merriam CV.
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
    [Abstract] [Full Text] [Related]

  • 3. Review of the in vitro activity of gemifloxacin against gram-positive and gram-negative anaerobic pathogens.
    Goldstein EJ.
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():55-65. PubMed ID: 10824034
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM, Molitoris E, Molitoris D, Finegold SM.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [Abstract] [Full Text] [Related]

  • 5. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
    Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell K.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
    Goldstein EJ, Conrads G, Citron DM, Merriam CV, Warren Y, Tyrrell K.
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):113-8. PubMed ID: 11858906
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
    Citron DM, Appleman MD.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis.
    Werner H, Heizmann WR, Höflsauer M.
    Infection; 1991 Jan; 19(5):377-9. PubMed ID: 1800380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    J Antimicrob Chemother; 1994 Oct; 34(4):579-84. PubMed ID: 7868409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria.
    Kleinkauf N, Ackermann G, Schaumann R, Rodloff AC.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1896-9. PubMed ID: 11353648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 17. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
    Ackermann G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC.
    Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
    [Abstract] [Full Text] [Related]

  • 18. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
    Goldstein EJ, Citron DM, Hudspeth M, Hunt Gerardo S, Merriam CV.
    J Antimicrob Chemother; 1998 Mar; 41(3):391-6. PubMed ID: 9578167
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM, Reznik T, Kutlin A, Hammerschlag MR.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2806-7. PubMed ID: 10543770
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.